What is Solu Therapeutics's official website?

Solu Therapeutics's website is http://www.solutherapeutics.com

How many employees are working in Solu Therapeutics right now?

Solu Therapeutics has 23 employees.

What is Solu Therapeutics's industry?

Solu Therapeutics's industry is Biotechnology Research

Who are Solu Therapeutics's top competitors?

Solu Therapeutics's top competitors are , , , , , ,

Solu Therapeutics company information, Employees & Contact Information

Updated May 2026

Quick answer

Solu Therapeutics is a Biotechnology Research company. It has approximately 23 employees on record. Contact data was last refreshed in May 2026. Find Solu Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Solu Therapeutics email format Solu Therapeutics management contacts

Related company profiles:

Solu Therapeutics is a precision-medicine company developing therapeutics to eliminate cells that drive oncologic, inflammatory, and autoimmune diseases.

Employees: 23
Address: Boston , Ma, Us
Industry: Biotechnology Research
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)
Website: http://www.solutherapeutics.com
HQ: Boston , MA
Competitors: Rapport Therapeutics, MOMA Therapeutics, Merida Biosciences, ADARx Pharmaceuticals Inc., Abcuro, Inc, Amplitude Therapeutics, Beam Therapeutics, Imbria Pharmaceuticals, FireCyte Therapeutics, Tevard Biosciences.

Solu Therapeutics Questions

News

Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies - PR Newswire

Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies PR Newswire

Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer - PR Newswire

Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer PR Newswire

Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer - MedCity News

Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer MedCity News

Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and Chief Executive Officer - Business Wire

Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and Chief Executive Officer Business Wire

Boston biotech Solu raises $41M Series A - Axios

Boston biotech Solu raises $41M Series A Axios

Solu Therapeutics Launches with $31 Million to Unlock Cell-Surface Targets - Genetic Engineering and Biotechnology News

Solu Therapeutics Launches with $31 Million to Unlock Cell-Surface Targets Genetic Engineering and Biotechnology News

Solu Therapeutics Closes $41M Series A Financing - FinSMEs

Solu Therapeutics Closes $41M Series A Financing FinSMEs

Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets - Business Wire

Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets Business Wire

Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting - PR Newswire

Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting PR Newswire

Companies like Solu Therapeutics

Top Solu Therapeutics Employees

Phillip Graham

Principal At Pappas Capital

Durham, North Carolina, United States, United States

View

3
duke.edu, mail.wlu.edu, promontory.com
Brandon Turunen

Oncology - Drug Discovery - Disruptive…

Boston, Massachusetts, United States, United States

View

3
gmail.com, gsk.com, gsk.com
Thomas Mathers

Executive Chairman, Aer Therapeutics…

Marblehead, Massachusetts, United States, United States

View

5
pappas-capital.com, colucid.com, peptimmune.com, peptimmune.com, allievex.com

14 +161764XXXXX
Enda Moran

Biotech Coo, Ceo | Biopharma…

Greater Boston, United States, United States

View

3
yahoo.co.uk, pfizer.com, matrivax.com

3 +197822XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Solu Therapeutics company information, Employees & Contact Information

Quick answer

Explore related pages

Company Details

Solu Therapeutics Questions

What is Solu Therapeutics's official website?

What is Solu Therapeutics's LinkedIn profile?

How many employees are working in Solu Therapeutics right now?

What is Solu Therapeutics's industry?

What are Solu Therapeutics's top competitors?

What are Solu Therapeutics's categories?

News

Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies - PR Newswire

Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer - PR Newswire

Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer - MedCity News

Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and Chief Executive Officer - Business Wire

Boston biotech Solu raises $41M Series A - Axios

Solu Therapeutics Launches with $31 Million to Unlock Cell-Surface Targets - Genetic Engineering and Biotechnology News

Solu Therapeutics Closes $41M Series A Financing - FinSMEs

Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets - Business Wire

Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting - PR Newswire

Companies like Solu Therapeutics

Rapport Therapeutics

Tevard Biosciences

Firecyte Therapeutics

Beam Therapeutics

Abcuro, Inc

Amplitude Therapeutics

Imbria Pharmaceuticals

Moma Therapeutics

Merida Biosciences

Adarx Pharmaceutical...

Top Solu Therapeutics Employees

Phillip Graham

Principal At Pappas Capital

Brandon Turunen

Oncology - Drug Discovery - Disruptive…

Thomas Mathers

Executive Chairman, Aer Therapeutics…

Enda Moran

Biotech Coo, Ceo | Biopharma…

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data